Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the public health system

• Grant number: 17/21240-0
• Support Opportunities: Scholarships abroad - Research Internship - Doctorate
• Start date: January 31, 2018
• End date: July 30, 2018
• Field of knowledge: Health Sciences - Collective Health - Public Health
• Principal Investigator: Leonardo Régis Leira Pereira
• Grantee: Maurilio de Souza Cazarim
• Supervisor: Olivia Wu
• Host Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
• Institution abroad: University of Glasgow, Scotland
• Associated to the scholarship: 16/03584-1 - DEVELOPMENT AND VALIDATION OF A PHARMACOECONOMIC TOOL FOR THE IMPLEMENTATION OF PHARMACEUTICAL CARE FOR HYPERTENSIVE PATIENTS IN THE PUBLIC HEALTH SYSTEM OF BRAZIL, BP.DR

Abstract

Introduction: The Health Economics and Health Technology Assessment center, supervised by Professor Olivia Wu, with interest in health technology assessment methodologies focuses on the areas of evidence synthesis with excellence in modeling, and systematic review applied to pharmacoeconomics. Objective: This sandwich project aims to improve the modeling and the application of data from a systematic review on pharmacoeconomics to improve the pharmacoeconomic tool. Methods: This project can be divided into three stages: 1) Data application of a systematic review on pharmacoeconomics; 2) Pharmacoeconomic analysis improvement; 3) Validate the model of Human Network Disease applied to pharmacoeconomics. Expected results: The increased level of research is reflected in the quality of schools of healthcare, which indirectly impacts on the quality of emergent professionals. Without performing such studies in Brazil, the advance of Brazilian science tends to be slower and more dependent on what is produced in developed countries, at the risk of the results not being applicable to the Brazilian population and Brazilian Public Health System (BPHS) reality. The results to be obtained will certainly contribute to improve the precision and acuity of the tool, and will guide the implementation of Health Technologies such as Pharmaceutical Care. In addition, the health planning promoted with the use of this tool will be able to optimize health resources, since the acquired savings can be reallocated to others health sectors and to the care of more costly morbidities to the BPHS and also improve the development of pharmacoeconomics in Brazil due to the results to be disclosed and the partnerships made, propitiating a better perspective for planning in the BPHS.

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

CAZARIM, MAURILIO DE SOUZA; DOS REIS, TIAGO MARQUES; COELHO DA CRUZ-CAZARIM, ESTAEL LUZIA; LEIRA PEREIRA, LEONARDO REGIS. Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care. Brazilian Journal of Pharmaceutical Sciences, v. 56, 2020. (17/21240-0, 16/03584-1)

MAURILIO DE SOUZA CAZARIM; JOÃO PAULO VILELA RODRIGUES; PRISCILA SANTOS CALCINI; THOMAS R. EINARSON; LEONARDO RÉGIS LEIRA PEREIRA. Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital. Revista de Saúde Pública, v. 54, 2020-09-30. (17/21240-0, 16/03584-1)

JOÃO PAULO VILELA RODRIGUES; MAURÍLIO DE SOUZA CAZARIM; SILVANA GAMA FLORENCIO CHACHÁ; ANA DE LOURDES CANDOLO MARTINELLI; LEONARDO RÉGIS LEIRA PEREIRA. Análise de custo-efetividade é uma estratégia essencial para os sistemas de saúde: as evidências de um estudo sobre terapias para hepatite C. Cadernos de Saúde Pública, v. 36, n. 2, 2020-01-31. (17/21240-0, 16/03584-1)